Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

Share Price is delayed by 15 minutes
Get Live Data
0.021    -0.002 (-8.70%)
Bid:
0.02
Ask:
0.022
Spread: 0.002 (10.00%)
Market Cap: £4.35m
IRON Live PriceLast checked at - London Stock Exchange

Intraday Ironveld Share Chart

Board Changes

29 Nov 2024 14:54

RNS Number : 2413O
Ironveld PLC
29 November 2024
 

29 November 2024

 

IRONVELD PLC

 

Board Changes

 

Ironveld PLC ("Ironveld" or the "Company"), the owner of a High Purity Iron ("HPI"), Vanadium, and Titanium project (the "Project"), located on the Northern Limb of the Bushveld Complex in Limpopo Province, South Africa, announces that Giles Clarke has informed the Company that he has taken the decision to retire from the Board and as a Non-Executive Director of Ironveld, with immediate effect.

 

In May 2024, Kristoffer Andersson was appointed as Chief Executive Officer of Ironveld and since this time has worked alongside Dr John Wardle, Executive Chairman, to identify key operational objectives and establish a strategy that would enable the Company to realise the value from the Project. As a result of the successful placing and subscription to raise £2.5 million, which completed in November 2024, the Company is now well placed to implement this strategy, and the Board looks forward to updating shareholders on progress in the coming months.

 

Following Giles Clarke's resignation and completion of the capital raise, John Wardle has assumed the role of Non-Executive Chairman of the Company.

 

John Wardle, Non-Executive Chairman, commented: "Giles has served on the Board of Ironveld since 2010 and I would like to thank him for the support and insight he has provided to the Company during this time. The Board wish Giles all the best for the future, and we now focus on a period when we expect to see transformation progress at the Project, including increased production, and the commencement of revenues and positive cash flow."

 

 

For further information, please contact:

 

Ironveld plc

Kristoffer Andersson, Chief Executive Officer

c/o BlytheRay

+44 20 7138 3204

 

Cavendish Capital Markets Limited (Nomad and Broker)

Derrick Lee / Adam Rae

+44 20 7220 0500

Turner Pope Investments (TPI) Ltd (Joint Broker)

Andrew Thacker / James Pope

+44 20 3657 0050

BlytheRay

Tim Blythe / Megan Ray

+44 20 7138 3204

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZKLFLZFLEFBL
Date   Source Headline
13th Mar 202311:15 amRNSResult of General Meeting
2nd Mar 202311:56 amRNSTR-1: Notification of major holdings
2nd Mar 202310:15 amRNSTR-1: Notification of major holdings
1st Mar 20235:36 pmRNSDirector Dealing
1st Mar 20234:56 pmRNSTR-1: Notification of major holdings
28th Feb 20234:15 pmRNSGrant of Share Options
24th Feb 20234:00 pmRNSPosting of GM Circular
24th Feb 20231:25 pmRNSTR-1: Notification of major holdings
23rd Feb 202311:00 amRNSPlacing to raise £2.0 million
15th Feb 20238:48 amRNSTR-1: Notification of major holdings
27th Jan 20237:00 amRNSDMS Grade Magnetite Joint Venture Agreement
17th Jan 202311:33 amRNSResult of Annual General Meeting
10th Jan 20237:00 amRNSFirst Production at Smelter
29th Dec 20222:49 pmRNSNotice of AGM
29th Dec 20222:30 pmRNSCorrection - Final Results year ended 30 June 2022
29th Dec 20227:00 amRNSFinal Results for the year ended 30 June 2022
21st Dec 20227:00 amRNSFCF Acquisition Update
9th Dec 20227:00 amRNSFCF Acquisition and Further Progress Update
6th Dec 20223:38 pmRNSTR-1: Notification of major holdings
2nd Nov 20227:00 amRNSBoard Appointment
1st Nov 202212:30 pmRNSCompletion of Debt Purchase Agreement
25th Oct 202211:04 amRNSTR-1: Notification of major holdings
24th Oct 20227:00 amRNSBlocklisting Return
17th Oct 20227:00 amRNSProgress Update
12th Sep 20227:00 amRNSUpdate on Power Generation Work Programme
31st Aug 20227:00 amRNSCompletion of Acquisition
12th Aug 20224:26 pmRNSResult of Requisitioned General Meeting
12th Aug 20229:44 amRNSTR-1: Notification of major holdings
11th Aug 20227:00 amRNSTR-1: Notification of major holdings
11th Aug 20227:00 amRNSCommencement of work at Smelter site
10th Aug 202210:26 amRNSTR-1: Notification of major holdings
4th Aug 20222:03 pmRNSTR-1: Notification of major holdings
4th Aug 20228:23 amRNSWithdrawal of Requisition for General Meeting
3rd Aug 20227:00 amRNSReplacement TR1: Notification of major holdings
2nd Aug 20225:33 pmRNSTR-1: Notification of major holdings
2nd Aug 20223:43 pmRNSDirector Share Dealing
1st Aug 202211:28 amRNSResult of General Meeting
21st Jul 202212:56 pmRNSTR-1: Notification of major holdings
15th Jul 20221:00 pmRNSResult of Broker Option and Posting of Circular
15th Jul 20227:30 amRNSBroker Option Closed
15th Jul 20227:00 amRNSPosting of Circular and Notice of General Meeting
13th Jul 20227:00 amRNSOversubscribed Placing of £4.0 million
12th Jul 20223:06 pmRNSTR-1: Notification of major holdings
8th Jul 20222:05 pmRNSSecond Price Monitoring Extn
8th Jul 20222:00 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSTR-1: Notification of major holdings
30th Jun 20225:47 pmRNSTR-1: Notification of major holdings
29th Jun 20228:33 amRNSProposed Requisition of General Meeting
24th Jun 20224:19 pmRNSTR-1: Notification of major holdings
20th Jun 20223:55 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.